Report Detail

Pharma & Healthcare COVID-19 Impact on Global Weight Loss and Obesity Management Market Size, Status and Forecast 2020-2026

  • RnM4062949
  • |
  • 16 June, 2020
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report focuses on the global Weight Loss and Obesity Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Weight Loss and Obesity Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Novo Nordisk
GlaxoSmithKline
Roche
Allergan
Johnson & Johnson
Medtronic
Vivus Inc
Eisai
Nalpropion Pharmaceuticals
ReShape Lifesciences
Obalon Therapeutics
Allurion Technologies
Beijing Noble Laser Technology

Market segment by Type, the product can be split into
Weight Loss and Obesity Management Devices
Weight Loss and Obesity Management Drugs
Market segment by Application, split into
Men
Women

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Weight Loss and Obesity Management status, future forecast, growth opportunity, key market and key players.
To present the Weight Loss and Obesity Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Weight Loss and Obesity Management are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Weight Loss and Obesity Management Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Weight Loss and Obesity Management Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Weight Loss and Obesity Management Devices
    • 1.4.3 Weight Loss and Obesity Management Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Weight Loss and Obesity Management Market Share by Application: 2020 VS 2026
    • 1.5.2 Men
    • 1.5.3 Women
  • 1.6 Coronavirus Disease 2019 (Covid-19): Weight Loss and Obesity Management Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Weight Loss and Obesity Management Industry
      • 1.6.1.1 Weight Loss and Obesity Management Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Weight Loss and Obesity Management Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Weight Loss and Obesity Management Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Weight Loss and Obesity Management Market Perspective (2015-2026)
  • 2.2 Weight Loss and Obesity Management Growth Trends by Regions
    • 2.2.1 Weight Loss and Obesity Management Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Weight Loss and Obesity Management Historic Market Share by Regions (2015-2020)
    • 2.2.3 Weight Loss and Obesity Management Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Weight Loss and Obesity Management Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Weight Loss and Obesity Management Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Weight Loss and Obesity Management Players by Market Size
    • 3.1.1 Global Top Weight Loss and Obesity Management Players by Revenue (2015-2020)
    • 3.1.2 Global Weight Loss and Obesity Management Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Weight Loss and Obesity Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Weight Loss and Obesity Management Market Concentration Ratio
    • 3.2.1 Global Weight Loss and Obesity Management Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Weight Loss and Obesity Management Revenue in 2019
  • 3.3 Weight Loss and Obesity Management Key Players Head office and Area Served
  • 3.4 Key Players Weight Loss and Obesity Management Product Solution and Service
  • 3.5 Date of Enter into Weight Loss and Obesity Management Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Weight Loss and Obesity Management Historic Market Size by Type (2015-2020)
  • 4.2 Global Weight Loss and Obesity Management Forecasted Market Size by Type (2021-2026)

5 Weight Loss and Obesity Management Breakdown Data by Application (2015-2026)

  • 5.1 Global Weight Loss and Obesity Management Market Size by Application (2015-2020)
  • 5.2 Global Weight Loss and Obesity Management Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Weight Loss and Obesity Management Market Size (2015-2020)
  • 6.2 Weight Loss and Obesity Management Key Players in North America (2019-2020)
  • 6.3 North America Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 6.4 North America Weight Loss and Obesity Management Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Weight Loss and Obesity Management Market Size (2015-2020)
  • 7.2 Weight Loss and Obesity Management Key Players in Europe (2019-2020)
  • 7.3 Europe Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 7.4 Europe Weight Loss and Obesity Management Market Size by Application (2015-2020)

8 China

  • 8.1 China Weight Loss and Obesity Management Market Size (2015-2020)
  • 8.2 Weight Loss and Obesity Management Key Players in China (2019-2020)
  • 8.3 China Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 8.4 China Weight Loss and Obesity Management Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Weight Loss and Obesity Management Market Size (2015-2020)
  • 9.2 Weight Loss and Obesity Management Key Players in Japan (2019-2020)
  • 9.3 Japan Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 9.4 Japan Weight Loss and Obesity Management Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Weight Loss and Obesity Management Market Size (2015-2020)
  • 10.2 Weight Loss and Obesity Management Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Weight Loss and Obesity Management Market Size by Application (2015-2020)

11 India

  • 11.1 India Weight Loss and Obesity Management Market Size (2015-2020)
  • 11.2 Weight Loss and Obesity Management Key Players in India (2019-2020)
  • 11.3 India Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 11.4 India Weight Loss and Obesity Management Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Weight Loss and Obesity Management Market Size (2015-2020)
  • 12.2 Weight Loss and Obesity Management Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Weight Loss and Obesity Management Market Size by Type (2015-2020)
  • 12.4 Central & South America Weight Loss and Obesity Management Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Novo Nordisk
    • 13.1.1 Novo Nordisk Company Details
    • 13.1.2 Novo Nordisk Business Overview and Its Total Revenue
    • 13.1.3 Novo Nordisk Weight Loss and Obesity Management Introduction
    • 13.1.4 Novo Nordisk Revenue in Weight Loss and Obesity Management Business (2015-2020))
    • 13.1.5 Novo Nordisk Recent Development
  • 13.2 GlaxoSmithKline
    • 13.2.1 GlaxoSmithKline Company Details
    • 13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.2.3 GlaxoSmithKline Weight Loss and Obesity Management Introduction
    • 13.2.4 GlaxoSmithKline Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.2.5 GlaxoSmithKline Recent Development
  • 13.3 Roche
    • 13.3.1 Roche Company Details
    • 13.3.2 Roche Business Overview and Its Total Revenue
    • 13.3.3 Roche Weight Loss and Obesity Management Introduction
    • 13.3.4 Roche Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.3.5 Roche Recent Development
  • 13.4 Allergan
    • 13.4.1 Allergan Company Details
    • 13.4.2 Allergan Business Overview and Its Total Revenue
    • 13.4.3 Allergan Weight Loss and Obesity Management Introduction
    • 13.4.4 Allergan Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.4.5 Allergan Recent Development
  • 13.5 Johnson & Johnson
    • 13.5.1 Johnson & Johnson Company Details
    • 13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.5.3 Johnson & Johnson Weight Loss and Obesity Management Introduction
    • 13.5.4 Johnson & Johnson Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.5.5 Johnson & Johnson Recent Development
  • 13.6 Medtronic
    • 13.6.1 Medtronic Company Details
    • 13.6.2 Medtronic Business Overview and Its Total Revenue
    • 13.6.3 Medtronic Weight Loss and Obesity Management Introduction
    • 13.6.4 Medtronic Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.6.5 Medtronic Recent Development
  • 13.7 Vivus Inc
    • 13.7.1 Vivus Inc Company Details
    • 13.7.2 Vivus Inc Business Overview and Its Total Revenue
    • 13.7.3 Vivus Inc Weight Loss and Obesity Management Introduction
    • 13.7.4 Vivus Inc Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.7.5 Vivus Inc Recent Development
  • 13.8 Eisai
    • 13.8.1 Eisai Company Details
    • 13.8.2 Eisai Business Overview and Its Total Revenue
    • 13.8.3 Eisai Weight Loss and Obesity Management Introduction
    • 13.8.4 Eisai Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.8.5 Eisai Recent Development
  • 13.9 Nalpropion Pharmaceuticals
    • 13.9.1 Nalpropion Pharmaceuticals Company Details
    • 13.9.2 Nalpropion Pharmaceuticals Business Overview and Its Total Revenue
    • 13.9.3 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Introduction
    • 13.9.4 Nalpropion Pharmaceuticals Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.9.5 Nalpropion Pharmaceuticals Recent Development
  • 13.10 ReShape Lifesciences
    • 13.10.1 ReShape Lifesciences Company Details
    • 13.10.2 ReShape Lifesciences Business Overview and Its Total Revenue
    • 13.10.3 ReShape Lifesciences Weight Loss and Obesity Management Introduction
    • 13.10.4 ReShape Lifesciences Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 13.10.5 ReShape Lifesciences Recent Development
  • 13.11 Obalon Therapeutics
    • 10.11.1 Obalon Therapeutics Company Details
    • 10.11.2 Obalon Therapeutics Business Overview and Its Total Revenue
    • 10.11.3 Obalon Therapeutics Weight Loss and Obesity Management Introduction
    • 10.11.4 Obalon Therapeutics Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 10.11.5 Obalon Therapeutics Recent Development
  • 13.12 Allurion Technologies
    • 10.12.1 Allurion Technologies Company Details
    • 10.12.2 Allurion Technologies Business Overview and Its Total Revenue
    • 10.12.3 Allurion Technologies Weight Loss and Obesity Management Introduction
    • 10.12.4 Allurion Technologies Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 10.12.5 Allurion Technologies Recent Development
  • 13.13 Beijing Noble Laser Technology
    • 10.13.1 Beijing Noble Laser Technology Company Details
    • 10.13.2 Beijing Noble Laser Technology Business Overview and Its Total Revenue
    • 10.13.3 Beijing Noble Laser Technology Weight Loss and Obesity Management Introduction
    • 10.13.4 Beijing Noble Laser Technology Revenue in Weight Loss and Obesity Management Business (2015-2020)
    • 10.13.5 Beijing Noble Laser Technology Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Weight Loss and Obesity Management. Industry analysis & Market Report on COVID-19 Impact on Global Weight Loss and Obesity Management is a syndicated market report, published as COVID-19 Impact on Global Weight Loss and Obesity Management Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Weight Loss and Obesity Management market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,131.70
    4,697.55
    6,263.40
    3,662.10
    5,493.15
    7,324.20
    602,706.00
    904,059.00
    1,205,412.00
    325,962.00
    488,943.00
    651,924.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report